Search International and National Patent Collections

1. (WO2018204894) METHOD FOR DETERMINING IN VITRO BIOEQUIVALENCE OF A SUCRALFATE SUSPENSION SAMPLE TO A SUCRALFATE SUSPENSION REFERENCE LISTED DRUG (RLD)

Pub. No.:    WO/2018/204894    International Application No.:    PCT/US2018/031262
Publication Date: Fri Nov 09 00:59:59 CET 2018 International Filing Date: Sat May 05 01:59:59 CEST 2018
IPC: G01N 33/50
Applicants: CLAYTON PHARMACEUTICALS LLC
Inventors: BHOOPATHY, Siddhartha
NANDI, Indranil
PATEL, Ami
HIDALGO, Ismael
Title: METHOD FOR DETERMINING IN VITRO BIOEQUIVALENCE OF A SUCRALFATE SUSPENSION SAMPLE TO A SUCRALFATE SUSPENSION REFERENCE LISTED DRUG (RLD)
Abstract:
The invention provides methods for determining in vitro bioequivalence of a sucralfate suspension sample to a sucralfate suspension RLD.